SHC
Income statement / Annual
Last year (2023), Sotera Health Company's total revenue was $1.05 B,
an increase of 4.54% from the previous year.
In 2023, Sotera Health Company's net income was $51.38 M.
See Sotera Health Company’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$1.05 B
|
$1.00 B
|
$931.48 M
|
$818.16 M
|
$778.33 M
|
$746.15 M
|
| Cost of Revenue |
$535.93 M |
$446.68 M |
$412.81 M |
$374.59 M |
$382.90 M |
$388.90 M |
| Gross Profit |
$513.36 M |
$557.00 M |
$518.67 M |
$443.57 M |
$395.43 M |
$357.25 M |
| Gross Profit Ratio |
0.49 |
0.55 |
0.56 |
0.54 |
0.51 |
0.48 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$133.36 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$156.88 M
|
$245.71 M
|
$198.16 M
|
$178.53 M
|
$147.48 M
|
$133.36 M
|
| Other Expenses |
$7.37 M |
$62.94 M |
$63.78 M |
$59.03 M |
$58.56 M |
$3.87 M |
| Operating Expenses |
$156.88 M |
$308.65 M |
$261.94 M |
$237.55 M |
$206.04 M |
$191.34 M |
| Cost And Expenses |
$692.81 M |
$755.34 M |
$674.75 M |
$612.14 M |
$588.94 M |
$580.24 M |
| Interest Income |
$0.00 |
$80.14 M |
$74.19 M |
$215.26 M |
$157.73 M |
$0.00 |
| Interest Expense |
$166.03 M |
$80.14 M |
$74.19 M |
$215.26 M |
$157.73 M |
$143.33 M |
| Depreciation &
Amortization |
$160.34 M
|
$147.75 M
|
$153.15 M
|
$145.51 M
|
$148.77 M
|
$148.15 M
|
| EBITDA |
$516.81 M
|
$317.73 M
|
$335.72 M
|
$274.46 M
|
$343.35 M
|
$316.60 M
|
| EBITDA Ratio |
0.49 |
0.32 |
0.36 |
0.34 |
0.44 |
0.42 |
| Operating Income Ratio
|
0.34
|
0.25
|
0.28
|
0.25
|
0.24
|
0.11
|
| Total Other
Income/Expenses Net |
-$250.45 M
|
-$491.46 M
|
-$81.02 M
|
-$244.88 M
|
-$184.51 M
|
$1.63 M
|
| Income Before Tax |
$106.03 M |
-$243.11 M |
$175.72 M |
-$38.86 M |
-$916,000.00 |
$24.22 M |
| Income Before Tax Ratio
|
0.1
|
-0.24
|
0.19
|
-0.05
|
-0
|
0.03
|
| Income Tax Expense |
$54.65 M |
-$9.54 M |
$58.60 M |
-$1.37 M |
$19.51 M |
$30.10 M |
| Net Income |
$51.38 M |
-$233.57 M |
$116.88 M |
-$37.49 M |
-$20.43 M |
-$5.87 M |
| Net Income Ratio |
0.05 |
-0.23 |
0.13 |
-0.05 |
-0.03 |
-0.01 |
| EPS |
0.18 |
-0.83 |
0.41 |
-0.13 |
-0.0718 |
-0.0238 |
| EPS Diluted |
0.18 |
-0.83 |
0.41 |
-0.13 |
-0.0718 |
-0.0238 |
| Weighted Average Shares
Out |
$281.01 M
|
$280.10 M
|
$279.23 M
|
$283.25 M
|
$284.42 M
|
$246.15 M
|
| Weighted Average Shares
Out Diluted |
$283.22 M
|
$280.10 M
|
$279.38 M
|
$283.25 M
|
$284.42 M
|
$246.15 M
|
| Link |
|
|
|
|
|
|
